Literature DB >> 20503406

Advances in imaging of inflammatory breast cancer.

Wei Tse Yang1.   

Abstract

The key roles of imaging in inflammatory breast cancer using mammography, sonography, magnetic resonance imaging, and positron emission tomography/computed tomography to facilitate image-guided biopsy for biomarker evaluation, delineate disease extent, diagnose distant metastases, and monitor response to therapy are described in this article. Copyright 2010 American Cancer Society.

Entities:  

Mesh：

Year:  2010        PMID： 20503406     DOI： 10.1002/cncr.25170

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  3 in total

1.  Inflammatory breast carcinoma.

Authors:  Kelli Y Ha; Shannon B Glass; Louba Laurie
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-04

2.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging in the Assessment of Inflammatory Breast Cancer Prior to and After Neoadjuvant Treatment.

Authors:  Dominique J P van Uden; J Hans W de Wilt; Carla Meeuwis; Charlotte F J M Blanken-Peeters; Ritse M Mann
Journal:  Breast Care (Basel)       Date:  2017-08-29       Impact factor: 2.860

3.  Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.

Authors:  D J P van Uden; M C van Maaren; L J A Strobbe; P Bult; J J van der Hoeven; S Siesling; J H W de Wilt; C F J M Blanken-Peeters
Journal:  Breast Cancer Res       Date:  2019-10-17       Impact factor: 6.466
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.